Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for Myopia
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A prospective comparison of eyes undergoing wavefront-guided LASIK in one eye and wavefront-guided PRK in their fellow eye for myopia.
| Condition | Intervention | Phase |
|---|---|---|
|
Myopia Astigmatism |
Procedure: Photorefractive keratectomy Procedure: Laser in-situ keratomileusis |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | A Prospective Randomized Eye to Eye Comparison of Fellow Eyes Undergoing Lasik With the IntraLase(TM) FS Versus PRK |
- Improvement in uncorrected visual acuity [ Time Frame: Baseline to one year ] [ Designated as safety issue: No ]
- Changes in best spectacle corrected visual acuity [ Time Frame: Baseline to one year ] [ Designated as safety issue: Yes ]
- Changes in 25 and 5% low contrast acuity [ Time Frame: baseline to one year ] [ Designated as safety issue: Yes ]
- Changes in quality of vision [ Time Frame: baseline to one year ] [ Designated as safety issue: Yes ]
- Comparison of dry eye signs and symptoms between LASIK and PRK [ Time Frame: baseline to one year ] [ Designated as safety issue: Yes ]
- Changes in quality of vision [ Time Frame: baseline to one year ] [ Designated as safety issue: No ]
- Changes in higher order aberrations [ Time Frame: Baseline to one year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 34 |
| Study Start Date: | August 2006 |
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | February 2014 (Final data collection date for primary outcome measure) |
-
Procedure: Photorefractive keratectomy
This is a research study comparing the outcomes of LASIK surgery to PRK surgery for nearsightedness when using the two different procedures. You will have one eye treated with LASIK using the Intralase FS laser and your other eye treated with PRK. You will be one of 100 sighted patients at Stanford to undergo treatment in this clinical research trial. This will be a prospective, randomized, research study in which up to 200 consecutive eyes scheduled to undergo excimer laser in situ keratomileusis (LASIK) in one eye and photorefractive keratectomy (PRK) in the fellow eye for the correction of myopia (nearsightedness) with or without astigmatism will be enrolled. The choice of which eye receives LASIK and which eye receives PRK will be randomized prior to enrollment. Randomization will be done according to a randomization schedule. You will know which eye is being treated with which procedure. The randomization will determine only whether your right or left eye is treated with the LASIK procedure. The other eye will be treated with PRK. You have a fifty percent chance of having your left eye treated with LASIK as your right eye. Subjects will undergo either bilateral (both eyes at once) wavefront (a more precise custom laser system) guided LASIK and PRK treatments using the VISX Star S4 excimer laser. All subjects will be followed for one year after the vision correction procedure. Subjects scheduled to undergo LASIK and PRK for the correction of myopia (nearsightedness) with or without astigmatism will be screened for eligibility. Eligible subjects will be examined preoperatively to establish a baseline for ocular condition (the general health and glasses prescription of the eyes). Postoperatively, subjects will undergo an ophthalmic evaluation (complete eye examination) at regular intervals as specified in this protocol. Retreatments (a second operation on the same eye for residual nearsightedness) will not be allowed during the first six months of this study. If you elect to undergo a retreatment of your LASIK or PRK surgery prior to the 6-month post-operative visit, the retreated eye will be exited from the study as of the retreatment date.
Any significant new finding developed during the course of the research which may relate to the subject's willingness to continue participation will be provided to the subject or subject's representative in a timely manner.
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Subjects age 21 and older with healthy eyes.
- Nearsightedness between -0.75 diopters and -7.00 diopters with or without astigmatism of up to -3.50 diopters.
Exclusion Criteria:
- Subjects under the age of 21.
- Patients with thin corneas.
- Patients with topographic irregularities.
- Patients with keratoconus.
- Patients with autoimmune diseases.
- Patients who are pregnant or nursing.
- Patients must have similar levels of nearsightedness in each eye. They can not be more than 1.0 diopter of difference between eyes.
- Patients must have similar levels of astigmatism in each eye. They can not have more than 1.0 diopter of difference between eyes.
Contacts and Locations| United States, California | |
| Stanford University School of Medicine | |
| Stanford, California, United States, 94305 | |
| Principal Investigator: | Edward E. Manche | Stanford University |
More Information
No publications provided by Stanford University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Edward E. Manche, Professor of Ophthalmology, Stanford University |
| ClinicalTrials.gov Identifier: | NCT01140594 History of Changes |
| Other Study ID Numbers: | SU-05192010-6082, SQL 97234 |
| Study First Received: | June 2, 2010 |
| Last Updated: | May 3, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Astigmatism Myopia Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on June 18, 2013